SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-028408
Filing Date
2018-05-15
Accepted
2018-05-15 08:01:56
Documents
42
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tv493476_10q.htm 10-Q 229003
2 EXHIBIT 10.1 tv493476_ex10-1.htm EX-10.1 27881
3 EXHIBIT 31.1 tv493476_ex31-1.htm EX-31.1 8133
4 EXHIBIT 31.2 tv493476_ex31-2.htm EX-31.2 8250
5 EXHIBIT 32.1 tv493476_ex32-1.htm EX-32.1 3272
  Complete submission text file 0001144204-18-028408.txt   2381488

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gnmx-20180331.xml EX-101.INS 535848
7 XBRL TAXONOMY EXTENSION SCHEMA gnmx-20180331.xsd EX-101.SCH 35665
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnmx-20180331_cal.xml EX-101.CAL 16632
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnmx-20180331_def.xml EX-101.DEF 177300
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnmx-20180331_lab.xml EX-101.LAB 196174
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnmx-20180331_pre.xml EX-101.PRE 189193
Mailing Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 610-254-4201
Aevi Genomic Medicine, Inc. (Filer) CIK: 0001138776 (see all company filings)

IRS No.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35112 | Film No.: 18833157
SIC: 2836 Biological Products, (No Diagnostic Substances)